Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 31 July

Grady Wulff
July 31, 2023

Weekly Wrap 28 July

Grady Wulff
July 28, 2023

Morning Bell 28 July

Sam Kanaan
July 28, 2023

Morning Bell 27 July

Grady Wulff
July 27, 2023

Morning Bell 26 July

Grady Wulff
July 26, 2023

Morning Bell 25 July

Sophia Mavridis
July 25, 2023

Morning Bell 24 July

Grady Wulff
July 24, 2023

Weekly Wrap 21 July

Grady Wulff
July 21, 2023

Morning Bell 21 July

Sophia Mavridis
July 21, 2023

Morning Bell 20 July

Sophia Mavridis
July 20, 2023

Morning Bell 19 July

Grady Wulff
July 19, 2023